Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers.

Asbestos-exposed workers (Asb) can sometimes develop lung impairments resembling idiopathic pulmonary fibrosis (IPF). Smoking is often a troubling confounder in the natural history of these lung diseases. Distal airspace epithelial cells, which are also altered in asbestosis, secrete Clara cell protein (CC-16, also designated CC-10) and surfactant-associated protein A (SP-A). By inhibiting phospholipase A2 (PLA2), CC-16 and SP-A are putative candidates for controlling lung inflammatory events. Both were measured with PLA2 activity in alveolar fluids (and sera for CC-16) of smoker and nonsmoker Asb and compared with smoking-matched normal subjects (N). CC-16 (in mg/L) was slightly increased in Asb and affected by smoking: nonsmoker Asb: 3.1 +/- 0.5 vs nonsmoker N: 1.9 +/- 0.2 (p < 0.05), smoker Asb: 1.7 +/- 0.3 vs smoker N: 0.6 +/- 0.1 (p < 0.05). SP-A (in microgram/mL) was enhanced in Asb but not affected by smoking: 5.4 +/- 1.5 in Asb vs 1.6 +/- 0.4 in N (p < 0.05), whereas SP-A to phosphorus ratio was increased in Asb but affected by smoking. CC-16 to albumin and CC-16 in serum to alveolar fluid ratios were altered by cigarette consumption in Asb (p < 0.05 vs N). Secretory PLA2 activity was slightly enhanced in Asb (p < 0.05 vs N). All data were similar between stages of disease. In summary, alveolar CC-16, SP-A, and secretory PLA2 activity were increased in Asb. Smoking affected several parameters. By this habit, Asb might reinforce lung profibrotic factors and increase their risk in developing lung alterations resembling IPF.

[1]  O. Lesur,et al.  Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. , 1995, American journal of respiratory and critical care medicine.

[2]  C. Dodia,et al.  Inhibition of lung calcium-independent phospholipase A2 by surfactant protein A. , 1994, The American journal of physiology.

[3]  R. Lauwerys,et al.  The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[4]  A. Mukherjee,et al.  Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin. , 1993, The Journal of biological chemistry.

[5]  J. Wright,et al.  Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. , 1993, The American journal of physiology.

[6]  J. Whitsett,et al.  Decreased surfactant protein A in patients with bacterial pneumonia. , 1993, The American review of respiratory disease.

[7]  J. Sallenave,et al.  Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. , 1993, American journal of respiratory cell and molecular biology.

[8]  R. Lauwerys,et al.  Clara cell protein in serum and bronchoalveolar lavage. , 1992, The European respiratory journal.

[9]  C. Gielens,et al.  Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[10]  J. J. Batenburg.  Surfactant phospholipids: synthesis and storage. , 1992, The American journal of physiology.

[11]  D. Schwartz,et al.  Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease. , 1992, The American review of respiratory disease.

[12]  C. R. Reed,et al.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. , 1991, The Journal of clinical investigation.

[13]  D. Schwartz,et al.  Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis. , 1991, Journal of applied physiology.

[14]  D. Voelker,et al.  Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. , 1991, The American review of respiratory disease.

[15]  J. Lund,et al.  Purification and level of expression in bronchoalveolar lavage of a human polychlorinated biphenyl (PCB)-binding protein: evidence for a structural and functional kinship to the multihormonally regulated protein uteroglobin. , 1991, American journal of respiratory cell and molecular biology.

[16]  W. Travis,et al.  Cellular and molecular basis of the asbestos-related diseases. , 1991, The American review of respiratory disease.

[17]  R. Auten,et al.  Surfactant apoprotein A (SP-A) is synthesized in airway cells. , 1990, American journal of respiratory cell and molecular biology.

[18]  S. Katyal,et al.  Clara cell 10 kDa protein (CC10): comparison of structure and function to uteroglobin. , 1990, Biochimica et biophysica acta.

[19]  S. Hawgood,et al.  Pulmonary surfactant and its apoproteins. , 1990, The Journal of clinical investigation.

[20]  M. Beato,et al.  Tissue-specific expression, hormonal regulation and 5'-flanking gene region of the rat Clara cell 10 kDa protein: comparison to rabbit uteroglobin. , 1990, Nucleic acids research.

[21]  J. Verhoef,et al.  Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.

[22]  A. Brody,et al.  Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchiolar-alveolar regions of the lungs of normal and complement deficient mice after inhalation of chrysotile asbestos. , 1989, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[23]  A. Cantin,et al.  Recent advances in the pathogenesis and clinical assessment of mineral dust pneumoconioses: asbestosis, silicosis and coal pneumoconiosis. , 1989, The European respiratory journal.

[24]  D. Voelker,et al.  Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat. , 1989, The American review of respiratory disease.

[25]  A. Brody,et al.  Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos-exposed rats. , 1989, The American journal of pathology.

[26]  Antonio Facchiano,et al.  Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I , 1988, Nature.

[27]  J. Whitsett,et al.  Surfactant Associated Protein (SAP‐35) in Amniotic Fluid FroMDiabetic and Nondiabetic Pregnancies , 1987, Obstetrics and gynecology.

[28]  Massaro Gd.  The Clara cell: secretory and developmental studies in the rat. , 1987 .

[29]  P. Vadas,et al.  Role of secretory phospholipases A2 in the pathobiology of disease. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[30]  M. Rola-Pleszczynski,et al.  Clinical features to stage alveolitis in asbestos workers. , 1985, American journal of industrial medicine.

[31]  D. Lamb,et al.  Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. , 1984, Thorax.

[32]  A. Churg,et al.  Morphology of small-airway lesions in patients with asbestos exposure. , 1984, Human pathology.

[33]  A. Brody,et al.  Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. , 1983, The American review of respiratory disease.

[34]  R. Bégin,et al.  Biochemical components of bronchoalveolar lavage in early experimental asbestosis of the sheep: phospholipase A2 activity, prostaglandin E2 and proteins. , 1983, Environmental health perspectives.

[35]  A. Churg,et al.  Small-airway lesions in patients exposed to nonasbestos mineral dusts. , 1983, Human pathology.

[36]  M. Rola-Pleszczynski,et al.  Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests. , 1983, Thorax.

[37]  V. Ferrans,et al.  Structure of alveolar epithelial cells in patients with fibrotic lung disorders. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[38]  V. Ferrans,et al.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.

[39]  M. J. Evans,et al.  Role of the Clara cell in renewal of the bronchiolar epithelium. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[40]  W. Roberts,et al.  Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. , 1977, The Journal of clinical investigation.